Compare ECOR & CDLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ECOR | CDLX |
|---|---|---|
| Founded | 2005 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Computer Software: Programming Data Processing |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 49.1M | 53.5M |
| IPO Year | 2018 | 2018 |
| Metric | ECOR | CDLX |
|---|---|---|
| Price | $7.08 | $0.87 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 1 | 2 |
| Target Price | ★ $18.00 | $2.25 |
| AVG Volume (30 Days) | 52.1K | ★ 1.2M |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 50.13 |
| EPS | ★ N/A | N/A |
| Revenue | $32,032,000.00 | ★ $233,273,000.00 |
| Revenue This Year | $33.60 | N/A |
| Revenue Next Year | $30.40 | $8.82 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 27.20 | N/A |
| 52 Week Low | $4.16 | $0.67 |
| 52 Week High | $8.30 | $3.28 |
| Indicator | ECOR | CDLX |
|---|---|---|
| Relative Strength Index (RSI) | 62.81 | 42.34 |
| Support Level | $4.55 | $0.84 |
| Resistance Level | $7.50 | $1.04 |
| Average True Range (ATR) | 0.48 | 0.06 |
| MACD | 0.08 | -0.01 |
| Stochastic Oscillator | 87.25 | 5.81 |
electroCore Inc is a bioelectronic technology company whose mission is to improve health and quality of life through non-invasive bioelectronic technologies. Its two commercial products are gammaCore non-invasive vagus nerve stimulation, or nVNS, and Quell Fibromyalgia, or Quell. It also sells Truvaga and TAC-STIM products, which are handheld, personal-use consumer products developed to promote general wellness and human performance. It operates in one segment: Bioelectronic Innovations. Geographically, it operates in the United States, the United Kingdom, Japan, and Other.
Cardlytics Inc is a commerce media platform that is designed to make commerce smarter and rewarding for everyone. At the core of its commerce media platform is the financial media network that it runs within its partners' digital channels, which includes online and mobile applications (the Cardlytics platform). Additionally, it operates an identity resolution platform that utilizes point-of-sale (POS) data, including product-level purchase data, to enable marketers to perform analytics and targeted loyalty marketing and also measure the impact of their marketing (the Bridg platform). It operates in three segments: the Cardlytics platform in the U.S.; the Cardlytics platform in the U.K.; and the Bridg platform. The majority of the revenue is derived from the Cardlytics platform.